Catalyst Wire Dossier Catalyst Wire Dossier

Brentuximab vedotin (Adcetris)

brentuximab vedotin
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Brentuximab vedotin (Adcetris), covering 2011-10-26 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients [Phase 2]

See pricing